Literature DB >> 17143889

Myopathy associated with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology.

Dalia Dimitri1, Chantal Andre, Jacques Roucoules, Hassan Hosseini, René-Louis Humbel, François-Jérôme Authier.   

Abstract

We report three patients with anti-signal recognition particle antibodies who had different presenting clinical pictures, mimicking acute polymyositis, limb-girdle muscular dystrophy, and acute rhabdomyolysis. Muscle biopsies typically showed necrotizing myopathy with little or no inflammation and deposits of membrane attack complex (C5b-9) in endomysial capillaries. The clinical course was severe in two patients and mild in one. The combination of corticosteroid with either an immunosuppressive agent or intravenous immunoglobulins was required to improve the condition of these patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17143889     DOI: 10.1002/mus.20693

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  12 in total

1.  A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy.

Authors:  Lisa Christopher-Stine; Livia A Casciola-Rosen; Grace Hong; Tae Chung; Andrea M Corse; Andrew L Mammen
Journal:  Arthritis Rheum       Date:  2010-09

2.  Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.

Authors:  Ritu Valiyil; Livia Casciola-Rosen; Grace Hong; Andrew Mammen; Lisa Christopher-Stine
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-09       Impact factor: 4.794

3.  MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD.

Authors:  Leo H Wang; Seth D Friedman; Dennis Shaw; Lauren Snider; Chao-Jen Wong; Chris B Budech; Sandra L Poliachik; Nancy E Gove; Leann M Lewis; Amy E Campbell; Richard J F L Lemmers; Silvère M Maarel; Stephen J Tapscott; Rabi N Tawil
Journal:  Hum Mol Genet       Date:  2019-02-01       Impact factor: 6.150

Review 4.  The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.

Authors:  Ilaria Cavazzana; Micaela Fredi; Carlo Selmi; Angela Tincani; Franco Franceschini
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 5.  Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.

Authors:  Leandro Ladislau; Louiza Arouche-Delaperche; Yves Allenbach; Olivier Benveniste
Journal:  Curr Rheumatol Rep       Date:  2018-08-03       Impact factor: 4.592

6.  Autoantibodies and their significance in myositis.

Authors:  Ira N Targoff
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

7.  Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study.

Authors:  Cécile Picard; Thierry Vincent; Jean-Christophe Lega; Sophie Hue; Françoise Fortenfant; Daniela Lakomy; René-Louis Humbel; Joelle Goetz; Nicolas Molinari; Nathalie Bardin; Daniel Bertin; Catherine Johanet; Pascale Chretien; Sylvain Dubucquoi; Nathalie Streichenberger; Sophie Desplat-Jégo; Xavier Bossuyt; Jean Sibilia; Isabelle Abreu; Alain Chevailler; Nicole Fabien
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

8.  Immune-mediated necrotizing myopathy, associated with antibodies to signal recognition particle, together with lupus nephritis: case presentation and management.

Authors:  John O'Grady; Len Harty; Nick Mayer; Val Critcher; John Ryan
Journal:  J Clin Med Res       Date:  2015-04-08

9.  Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients.

Authors:  Shigeaki Suzuki; Atsuko Nishikawa; Masataka Kuwana; Hiroaki Nishimura; Yurika Watanabe; Jin Nakahara; Yukiko K Hayashi; Norihiro Suzuki; Ichizo Nishino
Journal:  Orphanet J Rare Dis       Date:  2015-05-13       Impact factor: 4.123

10.  Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype.

Authors:  Yves Troyanov; Océane Landon-Cardinal; Marvin J Fritzler; José Ferreira; Ira N Targoff; Eric Rich; Michelle Goulet; Jean-Richard Goulet; Josiane Bourré-Tessier; Yves Robitaille; Julie Drouin; Alexandra Albert; Jean-Luc Senécal
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.